AT 56
目录号: A13032
L-PGDS 抑制剂
AT-56 是一种口服活性的 脂钙蛋白型前列腺素D合酶(L-PGDS)抑制剂(Ki = 75 μM,IC50 = 95 μM)。
Discription | AT-56 is am orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 μM, IC50 = 95 μM). |
---|
目录号 | A13032 |
---|---|
分子式 | C25H27N5 |
分子量 | 397.52 |
CAS号 | 162640-98-4 |
SMILES | C1CN(CCC1=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CCCCC5=NNN=N5 |
其他名称 | AT-56, AT56 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 74 mg/mL (186.15 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.16 mL | 125.78 mL | 251.56 mL |
0.5 mM | 5.03 mL | 25.16 mL | 50.31 mL |
1 mM | 2.52 mL | 12.58 mL | 25.16 mL |
5 mM | 0.5 mL | 2.52 mL | 5.03 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2